Kimia Farma's Net Profit Declines 11 Percent as of September: https://republika.co.id/berita/qj9eb7370/laba-bersih-kimia-farma-turun-11-persen-hingga-september/ 4 November 2020
PT Kimia Farma (Persero) Tbk experienced a decrease in net profit in the period January to September 2020. In the latest financial reports, the member of the BUMN Pharmacy holding company posted a net profit of IDR 37.20 billion or 11.07 percent decrease compared to the same period last year. which reached Rp. 41.83 billion.
The decline in net income occurred in fact at the same time as sales revenue, which increased by 2.47 percent from IDR 6.88 trillion to IDR 7.05 trillion. In the financial statements, the decrease in net profit was due to an increase in financial expenses, which increased from Rp 357.10 billion to Rp 447.76 billion.
Kimia Farma already has a strategy to face the MEA: http://www.jpnn.com/read/2014/10/16/263978/Kimia-Farma-Sudah-Punya-Strategi-Hadapi-MEA-16 October 2014
PT. Kimia Farma (Persero) expressed readiness to face the Asean Economic Community (AEC) by 2015. Various strategies have been done for the sake of state-owned companies face competition in the MEA.
Director of Research and Business Development Kimia Farma, Wahyuli Syafari said it would improve pharmaceutical manufacturers to face the ASEAN market. "Of course we are ready. The factory we have to improve its market share, one of them is to face the Asean market share," said Wahyuli at the headquarters of Kimia Farma, Veteran, Jakarta, Thursday (16/10).
Other strategies undertaken to address MEA Kimia Farma is to multiply the generic drug development. Therefore, it is rarely done other private pharmaceutical companies.
In addition, the pharmaceutical company also plans to produce raw materials for drugs. This was done because so far Indonesia still imports raw material for making the drug.
"Our strategy is that we develop generic drugs, because if the private-branded its (patent medicines, red). We will also produce raw materials, because of our weakness in the raw material. So far the majority of our imports. If you have the raw materials, that we can absorb, "he said.
Pharmaceutical, Chemical and Cosmetic Wholesaling in Indonesia
Indonesia Industry Report and Market Research
July 17, 2023
Industry Code : F61334
Forecast to : 2027
Definition
Pharmaceutical, Chemical and Cosmetic Wholesaling in Indonesia This Subgroup consists of establishments mainly engaged in wholesaling commodities of the basic chemical industries, various pharmaceutical products and herbal medicine, various types of soap and other cleaning agents, various types of cosmetics, perfume and other colouring agents for hair and skin.
Activities
The primary activities of firms in this industry are:
-
Wholesaling of medicine and pharmaceutical products.
-
Wholesaling of herbal medicine products.
-
Wholesaling of caustic soda.
-
Wholesaling of Colouring agents.
-
Wholesaling of glycerine.
-
Wholesaling of insecticides.
-
Wholesaling of pesticides.
-
Wholesaling of alcohol.
-
Wholesaling of volatile oils.
-
Wholesaling of soaps and other cleaning agents.
-
Wholesaling of cosmetics.
-
Wholesaling of perfumes.
-
Wholesaling of Colouring agents for hair and skin.
The Pharmaceutical, Chemical and Cosmetic Wholesaling industry in Indonesia research report contain trend analysis, statistics, market size information, industry growth rates as well as major competitors.
Major market segments are identified and also those forces affecting demand and supply within this industry. Performance analysis includes emerging industry trends as well as recent results and performance of each key company. Drawing on the depth of information DIS also provides 5 year forecasts for this industry.
The comprehensive study also examines details such as the barriers to entry, operating cost structure, technology & systems and domestic & international markets. Tables and statistics include: Industry revenue, exports, imports, wages and number of companies in the industry, Industry growth and geographic regional data.
